Table 2.
Comparison of immune factors in COVID-19 discharged patients.
| Immune factors | Reference range | Normal group | Self-reported Depression | P value |
|---|---|---|---|---|
| WBC (109/L) | 3.5–9.5 | 6.0 ± 1.5 | 6.7 ± 1.5*↑ | 0.016 |
| NEUT (109/L) | 1.8–6.3 | 3.3 ± 0.9 | 4.1 ± 1.2***↑ | 0.000 |
| LYM (109/L) | 1.1–3.2 | 1.9 ± 0.6 | 1.8 ± 0.5 | 0.468 |
| MON (109/L) | 0.1–0.6 | 0.5 ± 0.2 | 0.5 ± 0.2 | 0.744 |
| EOS (109/L) | 0.02–0.52 | 0.1 ± 0.1 | 0.1 ± 0.1 | 0.568 |
| BASO (109/L) | 0–0.06 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.800 |
| Neutrophil-to-Lymphocyte Ratio (NLR) | / | 1.8 ± 0.6 | 2.4 ± 0.9***↑ | 0.000 |
| NEUT ratio (%) | 40–75 | 55.7 ± 6.4 | 61.0 ± 7.1***↑ | 0.000 |
| LYM ratio (%) | 20–50 | 32.3 ± 6.3 | 28.1 ± 6.7**↓ | 0.002 |
| BASO ratio (%) | 0–1 | 0.7 ± 0.3 | 0.6 ± 0.3 | 0.107 |
| EOS ratio (%) | 0.4–8.0 | 2.2 ± 1.5 | 2.1 ± 1.4 | 0.741 |
| MONO ratio (%) | 3–10 | 9.0 ± 2.4 | 8.2 ± 2.6 | 0.148 |
| HS-CRP (mg/dL) | 0–0.5 | 0.1 ± 0.1 | 0.2 ± 0.3*↑ | 0.035 |
| IL-6 (pg/mL) | 1.5–5000 | 56.1 ± 105.3 | 40.7 ± 65.6 | 0.518 |
Continuous variables were analyzed using one-way ANOVA (Tamhane’s T2) test. *P < 0.05, **P < 0.01, ***P < 0.001 vs normal group. The symbols ↓ and ↑ represented significantly higher or lower.